Appen Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Appen wird ein jährliches Gewinn- und Umsatzwachstum von 97% bzw. 4.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 105.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -15.8% betragen.

Wichtige Informationen

97.0%

Wachstumsrate der Gewinne

105.3%

EPS-Wachstumsrate

IT Gewinnwachstum	17.8%
Wachstumsrate der Einnahmen	4.3%
Zukünftige Eigenkapitalrendite	-15.8%
Analystenabdeckung	Low
Zuletzt aktualisiert	03 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Appen Limited (ASX:APX) Stock Rockets 44% As Investors Are Less Pessimistic Than Expected

Oct 15

Appen Limited's (ASX:APX) Shares Bounce 28% But Its Business Still Trails The Industry

Aug 31

There's No Escaping Appen Limited's (ASX:APX) Muted Revenues Despite A 66% Share Price Rise

Feb 29

The Market Doesn't Like What It Sees From Appen Limited's (ASX:APX) Revenues Yet As Shares Tumble 27%

Jan 15

When Should You Buy Appen Limited (ASX:APX)?

Aug 24

Downgrade: Here's How Analysts See Appen Limited (ASX:APX) Performing In The Near Term

May 15

Why Appen Limited (ASX:APX) Could Be Worth Watching

May 10

Are Investors Undervaluing Appen Limited (ASX:APX) By 21%?

Apr 13

Should You Investigate Appen Limited (ASX:APX) At AU$2.61?

Dec 09

AU$4.47: That's What Analysts Think Appen Limited (ASX:APX) Is Worth After Its Latest Results

Aug 26

Appen Limited's (ASX:APX) Intrinsic Value Is Potentially 25% Below Its Share Price

May 26

Gewinn- und Umsatzwachstumsprognosen

ASX:APX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	265	-5	3	17	4
12/31/2025	241	-11	-1	13	5
12/31/2024	224	-25	0	12	5
6/30/2024	248	-93	-36	-21	N/A
3/31/2024	261	-105	-39	-22	N/A
12/31/2023	274	-118	-43	-23	N/A
9/30/2023	309	-196	-30	-6	N/A
6/30/2023	345	-273	-17	11	N/A
3/31/2023	367	-256	-13	15	N/A
12/31/2022	388	-239	-10	18	N/A
9/30/2022	411	-113	6	32	N/A
6/30/2022	434	12	22	45	N/A
3/31/2022	440	20	27	49	N/A
12/31/2021	447	29	31	54	N/A
9/30/2021	428	28	24	49	N/A
6/30/2021	409	27	18	44	N/A
3/31/2021	411	32	31	54	N/A
12/31/2020	413	36	44	65	N/A
9/30/2020	411	34	51	69	N/A
6/30/2020	401	31	57	71	N/A
3/31/2020	354	27	43	55	N/A
12/31/2019	376	29	36	47	N/A
9/30/2019	335	30	37	44	N/A
6/30/2019	320	33	40	45	N/A
3/31/2019	291	31	36	39	N/A
12/31/2018	257	29	30	33	N/A
9/30/2018	220	22	20	24	N/A
6/30/2018	182	15	9	14	N/A
3/31/2018	158	13	N/A	12	N/A
12/31/2017	130	11	N/A	10	N/A
9/30/2017	117	11	N/A	12	N/A
6/30/2017	101	10	N/A	14	N/A
3/31/2017	93	9	N/A	12	N/A
12/31/2016	80	8	N/A	9	N/A
9/30/2016	81	8	N/A	9	N/A
6/30/2016	75	8	N/A	9	N/A
3/31/2016	70	7	N/A	6	N/A
12/31/2015	60	6	N/A	3	N/A
9/30/2015	50	4	N/A	3	N/A
6/30/2015	46	2	N/A	3	N/A
3/31/2015	42	1	N/A	5	N/A
12/31/2014	42	1	N/A	7	N/A
12/31/2013	54	1	N/A	5	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: APX wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).

Ertrag vs. Markt: APX wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: APX wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: APXDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Australian (5.7% pro Jahr).

Hohe Wachstumseinnahmen: APXDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: APX wird voraussichtlich in 3 Jahren unrentabel sein.

Appen Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus estimates of losses per share improve by 31%

Price target increased by 10% to AU$0.92

Consensus EPS estimates fall by 27%

Price target increased by 8.7% to AU$0.58

Consensus estimates of losses per share improve by 16%

Price target decreased by 7.6% to AU$0.63

Recent updates

Consensus estimates of losses per share improve by 31%

Appen Limited has completed a Follow-on Equity Offering in the amount of AUD 50.000001 million.

Appen Limited (ASX:APX) Stock Rockets 44% As Investors Are Less Pessimistic Than Expected

Appen Limited has completed a Follow-on Equity Offering in the amount of AUD 50.000001 million.

New major risk - Shareholder dilution

Appen Limited to Report Q3, 2024 Results on Oct 31, 2024

Price target increased by 10% to AU$0.92

First half 2024 earnings released: US$0.081 loss per share (vs US$0.34 loss in 1H 2023)

Appen Limited's (ASX:APX) Shares Bounce 28% But Its Business Still Trails The Industry

Consensus EPS estimates fall by 27%

Price target increased by 8.7% to AU$0.58

Appen (ASX:APX) Will Have To Spend Its Cash Wisely

Appen Limited to Report First Half, 2024 Results on Aug 30, 2024

Appen Limited's (ASX:APX) Price Is Right But Growth Is Lacking

We're A Little Worried About Appen's (ASX:APX) Cash Burn Rate

Appen Limited, Annual General Meeting, May 24, 2024

Appen Limited, Annual General Meeting, May 24, 2024

Consensus estimates of losses per share improve by 16%

New major risk - Financial position

Now 28% undervalued

High number of new directors

There's No Escaping Appen Limited's (ASX:APX) Muted Revenues Despite A 66% Share Price Rise

Price target decreased by 7.6% to AU$0.63

Full year 2023 earnings released: US$0.83 loss per share (vs US$1.94 loss in FY 2022)

Consensus EPS estimates upgraded to US$0.34 loss

New major risk - Share price stability

The Market Doesn't Like What It Sees From Appen Limited's (ASX:APX) Revenues Yet As Shares Tumble 27%

Appen Limited to Report Fiscal Year 2023 Results on Feb 27, 2024

New major risk - Shareholder dilution

Appen Limited has filed a Follow-on Equity Offering in the amount of AUD 30 million.

Price target decreased by 9.1% to AU$1.43

New minor risk - Share price stability

New minor risk - Market cap size

New minor risk - Profitability

New minor risk - Profitability

Consensus EPS estimates fall by 18%

Price target decreased by 11% to AU$2.13

When Should You Buy Appen Limited (ASX:APX)?

Appen Launches AI Chat Feedback and Benchmarking Solutions for Enhanced LLM Evaluation

Appen Limited Announces Chief Financial Officer Changes

Appen Limited Announces Appointment of Fab Dolan as Chief Marketing Officer

Appen Limited to Report First Half, 2023 Results on Aug 28, 2023

Price target increased by 9.8% to AU$2.17

Appen Limited Appoints Andrew Ettinger as Chief Revenue Officer

Downgrade: Here's How Analysts See Appen Limited (ASX:APX) Performing In The Near Term

Price target decreased by 12% to AU$2.05

Consensus EPS estimates fall by 52%

Why Appen Limited (ASX:APX) Could Be Worth Watching

Now 34% undervalued after recent price drop

Now 20% undervalued

Are Investors Undervaluing Appen Limited (ASX:APX) By 21%?

Now 21% undervalued

Independent Non-Executive Director recently bought AU$124k worth of stock

Consensus EPS estimates fall by 98%

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased by 12% to AU$2.67

Consensus EPS estimates upgraded to US$0.13 loss, revenue downgraded

Price target decreased by 7.1% to AU$2.94

Consensus EPS estimates upgraded to US$0.14 loss, revenue downgraded

Investor sentiment improves as stock rises 15%

Appen Limited, Annual General Meeting, May 26, 2023

Appen Limited to Report Fiscal Year 2022 Results on Feb 27, 2023

Consensus EPS estimates fall by 13%

Appen Limited Appoints Mr. Ahmad Armughan as Director

Appen Limited Announces Chief Executive Officer Changes

Appen Limited Announces Management Changes

Investor sentiment deteriorated over the past week

Should You Investigate Appen Limited (ASX:APX) At AU$2.61?

High number of new directors